AVE 0.00% 0.3¢ avecho biotechnology limited

marketing is the key to poh growth, page-54

  1. 563 Posts.
    lightbulb Created with Sketch. 1
    Thanks KARICOUM, so it would seem the April 8 presentation was more a conservative estimate expecting to be cash flow positive by 2014 but if things go well they could be there by the end of 2012. Still implies a cap raising on the more optimistic timetable in the absence of a deal especially if they are to fund phase 3 oxy.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.508M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 484999 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 485000 3
View Market Depth
Last trade - 09.04am 28/06/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.